Vitreous Tamponades Market
In the recent years, vitreoretinal surgery has made prominent progress with respect to the drugs, materials and instrumentation. Several ophthalmic conditions such as diabetic retinopathy, proliferative vitreoretinopathy and diabetic retinopathy total or partial vitreous removal.
At present, permanent and temporary vitreous substitutes have structural function for ensuring retinal adherence following retinopexy or for control of intraocular hemorrhages and maintenance of intraocular pressure. It is anticipated that, the future polymers used as vitreous substitutes will favorably interact with the intraocular anatomy along with ensuring appropriate intraocular drug distribution. However, one of the most significant challenges is with respect to the control of immune reactions modifying stability of substitutes and functionality of intraocular structures.
Browse the full report Vitreous Tamponades Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/vitreous-tamponades-market
Market Insights
Vitreous tamponades are used in vitrectomy surgeries for reattachment of the retina and treatment of other vitreous deformations. These products are often used for treatment of retinal disorders during retinal surgery and post-surgery recovery measure. Some of the common conditions where vitreous tamponades are sued during treatment are retinitis pigmentosa, diabetic retinopathy, retinal degeneration, retinal detachment, macular hole, macular edema, retinopathy or prematurity, uveitis, vascular occlusion and so on. Vitreous occupies the gap between the eye lens and the retina; and since it cannot regenerate, this cavity needs to be refilled with substitute through surgery. Gas and liquid vitreous tamponades are the ideal choice during surgical interventions.
Stable growth of the global vitreous tamponades market is driven by increasing incidence of retinal conditions such as diabetic retinopathy, retinal detachments, etc. the global incidence of diabetes is increasing, thereby paving way for increased patient pool for diabetic reinopathy, consequently increasing the demand for vitreous tamponades in vitrectomy.
Ongoing developments in the field of vitreoretinal surgery has also augmented the need for appropriate vitreous substitutes. An ideal substitute is expected to maintain all the biochemical and physical characteristics of the natural vitreous. Furthermore, as new surgical techniques with smaller instruments have been introduced in the market with proven safety profiles, there has been a consistent growth in the number of patients opting for such surgeries. This has also led to the use of more viscous vitreous substitutes.
Growing incidence of vitreoretinal disorders and diabetes complications such as diabetic retinopathy is a key driver of this market. These conditions are treated with vitrectomy which involves removal of the vitreous humor along with replacement with synthetic substitute. Additionally, increasing geriatric population is also considered as one of the prominent factors positively impacting the market growth. Based on the competitive scenario, this market is witnessing presence of a limited number of players, which further enjoy regional dominance.
To know more insightful information, click here @
Report Scope By Type (2016–2026; US$ Mn)
Gas Tamponades
Sulfur Hexafluoride (SF6)
Perfluoroethane (C2F6)
Perfluoropropane (C3F8)
Liquid Tamponades
Silicone Oil
Perfluorocarbon Liquids (PFCL)
Asia Pacific to witness rapid growth in demand for vitreous tamponades
In 2017, North America is estimated as the largest regional market for vitreous tamponades, followed by Europe. Widespread usage of vitreous tamponades in ocular surgeries, greater awareness and favorable reimbursements are the key factors that support the dominance of these regions. On the other hand, these regions also witness fastest adoption of new technologies and methods in the mainstream operations due to favorable regulations, better purchasing powers and domicile of major market players. On the other hand, Asia Pacific market shall be advancing at rapid growth rate registering higher than the global benchmark. Rapid growth of the healthcare infrastructure in the region, and high prevalence of diabetes and therefore diabetic retinopathy along with improving awareness in the healthcare providers are supporting the pace of Asia Pacific market. Furthermore, the development of Asia Pacific market as a hub for medical tourism will open additional growth opportunities in the region.
Key questions answered in this report
What is the current and projected market size of the global vitreous tamponades market during the period 2016 to 2026?
Which product type shall be expected to witnessing significant growth in demand during the forecast period?
Will the rapid growth of the Asia Pacific market will result in the region surpass the dominance of North America?
What are the key strategies adopted and implemented by the market players for gaining competitive edge?
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives.
Contact:
Name: Chris Smith
Designation: Global Sales Manager
E-mail: sales@credenceresearch.com
Ph: 1-800-361-8290
Web: https://www.credenceresearch.com
Aman Jain
Credence Research inc
aman@credenceresearch.com
https://www.credenceresearch.com/report/vitreous-tamponades-market